Lexicon Pharmaceuticals to Participate in December Investor Conferences
THE WOODLANDS, Texas, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company…
3,619€
-0,90%
Echtzeit-Aktienkurs Lexicon Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Lexicon Pharmaceuticals Inc. Aktie
Lexicon Appoints Ivan H. Cheung to Board of Directors
THE WOODLANDS, Texas, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Ivan…
Lexicon Pharmaceuticals: Exklusive Partnerschaft mit Viatris bietet gemäß der Experten gigantisches Potenzial!
Lexicon Pharmaceuticals Inc. (LXRX) ist ein Biotech mit Fokus auf Behandlungsmethoden von schwerwiegenden chronischen Krankheiten. Das Unternehmen nutzt dabei die…
Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Disease Among Three Lexicon-Sponsored Presentations at the 2024 Annual Conference of the Association of Diabetes Care & Education Specialists
THE WOODLANDS, Texas, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that three…
Lexicon Pharmaceuticals, Inc. 2024 Q2 - Results - Earnings Call Presentation
…
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2024 Earnings Call Transcript
…
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation…
Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2024 Earnings Call Transcript
…
Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset
…
Lexicon Pharmaceuticals secures $250 million in private financing By Investing.com
Lexicon Pharmaceuticals secures $250 million in private financing…
Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
THE WOODLANDS, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced it…
Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
…
Lexicon Pharmaceuticals: Navigating The Competitive HFpEF Landscape (Rating Downgrade)
…
Lexicon Pharmaceuticals to offer up to $75M in common stock under agreement
…
MSCLF: AAK1 Disclosed as Drug Target for DMD Program…
By David Bautz, PhD
OTC:MSCLF
READ THE FULL MSCLF RESEARCH REPORT
Business Update
AAK1 Disclosed as Drug Target for DMD Program
On November 14, 2023,…
Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference
THE WOODLANDS, Texas, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation…
Lexicon Pharmaceuticals to Participate in the Jefferies London Healthcare Conference
THE WOODLANDS, Texas, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation…
Lexicon Pharmaceuticals, Inc. (LXRX) Q3 2023 Earnings Call Transcript
…
Lexicon Pharmaceuticals to Host Third Quarter 2023 Financial Results Conference Call and Webcast on November 8, 2023
THE WOODLANDS, Texas, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its third…
Lexicon Pharmaceuticals says Debbane buys 1M shares in company
…
Lexicon Pharmaceuticals to Participate in the H.C. Wainwright & Co. 25th Annual Global Investment Conference
THE WOODLANDS, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation…
Insiderhandel: Chief Executive Officer kauft Aktien von Lexicon Pharmaceuticals im Wert von 21.600$
Coats, Lonnel - Vorstand - Tag der Transaktion: 2023-06-29...…
Insiderhandel: VP, Human Resources kauft Aktien von Lexicon Pharmaceuticals im Wert von 24.300$
Mcdermott, Wendy - Vorstand - Tag der Transaktion: 2023-06-23...…
Insiderhandel: Chief Executive Officer kauft Aktien von Lexicon Pharmaceuticals im Wert von 24.950$
Coats, Lonnel - Vorstand - Tag der Transaktion: 2023-06-23...…
Insiderhandel: Chief Executive Officer kauft Aktien von Lexicon Pharmaceuticals im Wert von 21.792$
Coats, Lonnel - Vorstand - Tag der Transaktion: 2023-06-26...…